SCHEMBL6267455

SCHEMBL6267455

C=C(C1CC1)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11066956 0.86 TSHR (0.39)
SCHEMBL5929221 0.84 CES2 (0.42)
SCHEMBL3193277 0.81 CES2 (0.47)
SCHEMBL3185717 0.81 CES2 (0.47)
SCHEMBL19736112 0.76 EPHX2 (0.30)
SCHEMBL805192 0.74 TSHR (0.30)
SCHEMBL19054518 0.72
SCHEMBL23743496 0.71 ALDH1A1 (0.50)
SCHEMBL15140884 0.71 HPGD (0.37)
SCHEMBL23418989 0.70 NOS2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0419297-B1 Process for the separation of optical isomers from 1,4-dihydropyridine derivatives ADIR (FR) 1994-06-08 EP claimed
EP-0259206-B1 DERIVATIVES OF 1,4-DIHYDROPYRIDINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ADIR ET COMPAGNIE (FR) 1991-10-09 EP claimed
EP-0419297-A1 Process for the separation of optical isomers from 1,4-dihydropyridine derivatives ADIR ET COMPAGNIE (FR) 1991-03-27 EP claimed
EP-0259206-A1 Derivatives of 1,4-dihydropyridine, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1988-03-09 EP claimed
WO-2021139595-A1 RORγT INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 东莞市东阳光新药研发有限公司 2021-07-15 WO disclosed
EP-1606244-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT Abbott Laboratories (US) 2005-12-21 EP disclosed
US-20040209858-A1 Cycloalkylamides and their therapeutic applications ABBOTT LABORATORIES 2004-10-21 US disclosed
WO-2004037769-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT ABBOTT LABORATORIES (US) 2004-05-06 WO disclosed
US-20040077618-A1 Cycloalkylamides and their therapeutic applications ABBOTT LABORATORIES 2004-04-22 US disclosed
EP-0775132-B1 (AZETIDIN-1-YLALKYL)LACTAMS AS TACHYKININ ANTAGONISTS PFIZER LTD (GB) 2001-03-28 EP disclosed
US-5968923-A ANTIINFLAMMATORY AGENTS, TREATMENT OF NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS PFIZER INC. (US) 1999-10-19 US disclosed
EP-0349195-B1 Direct synthesis by cationic polymerization of nitrogen-containing polymers EXXON CHEMICAL PATENTS INC (US) 1997-05-21 EP disclosed
EP-0419297-A1 Process for the separation of optical isomers from 1,4-dihydropyridine derivatives ADIR ET COMPAGNIE (FR) 1991-03-27 EP disclosed
EP-0349195-A2 Direct synthesis by cationic polymerization of nitrogen-containing polymers EXXON CHEMICAL PATENTS INC. (US) 1990-01-03 EP disclosed
EP-0128654-B1 GEM-DIAMINOALKANE DERIVED SWEETENERS CUMBERLAND PACKING CORPORATION (US) 1989-10-18 EP disclosed
EP-0259206-A1 Derivatives of 1,4-dihydropyridine, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1988-03-09 EP disclosed
EP-0259206-A1 Derivatives of 1,4-dihydropyridine, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1988-03-09 EP disclosed
EP-0242896-A2 Novel intermediates useful in the production of gem-diaminoalkane derived sweeteners CUMBERLAND PACKING CORPORATION (US) 1987-10-28 EP disclosed
US-4571345-A 1,1-Diaminoalkane derived sweeteners CUMBERLAND PACKING CORP. (US) 1986-02-18 US disclosed
EP-0128654-A2 Gem-diaminoalkane derived sweeteners CUMBERLAND PACKING CORPORATION (US) 1984-12-19 EP disclosed